Alembic Pharma Q1 PAT rises 12% YoY to Rs 135 cr

The pharmaceutical company's consolidated net profit increased 11.69% to Rs 134.71 crore in Q1 FY25 as compared to Rs 120.60 crore posted in Q1 FY24.